Tilray Sirius is making its mark internationally, most recently becoming available in Polish pharmacies. The strain features a unique terpene profile with elements like caryophyllene and limonene, which contribute to its aroma and health benefits, along with a high THC content of around 18% and low CBD content below 1%, making it well known for pain relief and stress management.
In Polish pharmacies, the famed cannabis strain, Tilray Sirius, is arriving. Tilray Sirius is a hybrid strain, 60% Indica and 40% Sativa in composition. It likely originates from the areas of Northern California and Afghanistan.
Although the medicine goes by the name “Tilray Sirius,” its original strain is Alien Dawg. Alien Dawg was initially created by crossing Alien Technology and Chemdawg strains, from which it derives its name.
For more news like this, download our free cannabis news app.
The terpene profile of the Tilray Sirius strain includes several key terpenes affecting its aroma and effects. Here is a description of these terpenes and their vaporization temperatures:
These terpenes work together to create a unique terpene profile for the Tilray Sirius strain. However, it’s essential to remember that different terpenes have different vaporization temperatures, meaning you can tailor your vaporization experience by controlling the heating temperature. This allows for better extraction of specific terpenes and their health benefits.
The terpenes impart to Tilray Sirius distinctive aromas that include notes of:
Tilray Sirius is particularly suitable for evening use due to its strong sedative effects, which often induce a feeling of relaxation and drowsiness. Despite these sedative effects, Tilray Sirius can also improve mood, even with low consumption, allowing for a relaxing and enjoyable experience.
The main benefits of medical cannabis from the Tilray Sirius strain include pain relief, aid in stress and insomnia management, and reduction of inflammatory states. It also acts as a natural anti-inflammatory agent. However, keep in mind that it has a low CBD content, below 1%, and a high THC level, around 18%, making it quite potent.
Tilray Sirius can help people suffering from chronic pain, stress, depression, eating disorders, and insomnia. However, it’s crucial to remember the possible side effects, such as dry mouth, dry eyes, paranoia, anxiety, and dizziness. Therefore, it’s essential to use this strain moderately and under appropriate conditions. Novice consumers should start with low doses to avoid potential adverse effects.
In summary, Tilray Sirius is a new medical cannabis strain available in Polish pharmacies. It is a hybrid strain with strong sedative effects, which may help in pain relief, stress reduction, and mood enhancement. However, caution is advised due to its high THC content and possible side effects.
It’s also worth noting that Tilray supplies pharmacies with other strains, such as Jack Herer and Blueberry, are also available in pharmacies and should be considered.
—
(Featured image by Alexander Grey via Unsplash)
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
A survey found that women comprise 61% of home cannabis growers, marking a diversion from…
Denmark plans to make its pilot medical cannabis program permanent following its success in treating…
Polish lawmakers have submitted a non-binding petition to Prime Minister Donald Tusk, urging cannabis decriminalization…
The UK medical cannabis market has rapidly grown since legalization in 2018, with private actors…
A new study involving over 23,000 participants in New Zealand found that 60% of people…
The French Ministers of the Interior and Justice announced a comprehensive plan to tackle organized…